prednisolone has been researched along with Debility in 3 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The German Maintenance Study (GERMAIN) was designed to evaluate the impact of lenalidomide maintenance after induction therapy with bortezomib, melphalan and prednisolone (VMP) in transplant-ineligible newly diagnosed multiple myeloma (MM) patients." | 5.34 | Frailty impairs the feasibility of induction therapy but not of maintenance therapy in elderly myeloma patients: final results of the German Maintenance Study (GERMAIN). ( Brioli, A; Fabisch, C; Hänel, M; Hochhaus, A; Illmer, T; Knop, S; Krammer-Steiner, B; Manz, K; Mügge, LO; Pfirrmann, M; Prange-Krex, G; Schwarzer, AC; von Lilienfeld-Toal, M, 2020) |
| "Age, frailty score and CRP at presentation were independently associated with mortality; all deaths occurred in patients aged over 75 at presentation." | 1.56 | Long-term outcomes in elderly patients with ANCA-associated vasculitis. ( Dhaun, N; Farrah, TE; Gallacher, PJ; Hunter, RW; Kluth, DC; McGovern, D; Miller-Hodges, E; Parsons, K; Williams, SP, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brioli, A | 1 |
| Manz, K | 1 |
| Pfirrmann, M | 1 |
| Hänel, M | 1 |
| Schwarzer, AC | 1 |
| Prange-Krex, G | 1 |
| Fabisch, C | 1 |
| Knop, S | 1 |
| Illmer, T | 1 |
| Krammer-Steiner, B | 1 |
| Hochhaus, A | 1 |
| von Lilienfeld-Toal, M | 1 |
| Mügge, LO | 1 |
| McGovern, D | 1 |
| Williams, SP | 1 |
| Parsons, K | 1 |
| Farrah, TE | 1 |
| Gallacher, PJ | 1 |
| Miller-Hodges, E | 1 |
| Kluth, DC | 1 |
| Hunter, RW | 1 |
| Dhaun, N | 1 |
| Okamura, M | 1 |
| Hamaguchi, M | 1 |
| Suzuki, K | 1 |
| Nakamura, T | 1 |
| Fujita, H | 1 |
| Hirata, K | 1 |
1 review available for prednisolone and Debility
| Article | Year |
|---|---|
[A patient with neurosarcoidosis presenting with easy falling and dysphagia].
Topics: Accidental Falls; Aged; Central Nervous System Diseases; Deglutition Disorders; Diagnosis, Different | 2020 |
1 trial available for prednisolone and Debility
| Article | Year |
|---|---|
Frailty impairs the feasibility of induction therapy but not of maintenance therapy in elderly myeloma patients: final results of the German Maintenance Study (GERMAIN).
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Double-Blind Me | 2020 |
1 other study available for prednisolone and Debility
| Article | Year |
|---|---|
Long-term outcomes in elderly patients with ANCA-associated vasculitis.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Neutrophil Cytoplasmic Antibody-Associated Vascu | 2020 |